Riskpilot← Back to searchSign inGet full accessGILEAD SCIENCES DENMARK ApS
APSActiveCVR 30899032Gammel Kongevej 60Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 200710 employees
Revenue 2024
DKK 174,3M
+59% vs 2023
EBITDA margin
3.4%
+52% vs 2023
Equity ratio
59.2%
Financial strength
Net profit 2024
DKK 5,9M
+83% vs 2023
| Revenue | DKK 174,3M | +59% |
| EBITDA | DKK 6M | +52% |
| Net profit | DKK 5,9M | +83% |
| Total assets | DKK 101,3M | +19% |
| Equity | DKK 60M | +11% |
| Employees | 10 | — |
Legal name
GILEAD SCIENCES DENMARK ApS
CVR number
30899032
Legal form
Anpartsselskab
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
25. september 2007
Share capital
DKK 125.000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af bestyrelsen, af en direktør eller af den samlede bestyrelse.
Company purpose
Selskabets formål er import, marketing, emballering, salg, distribution, forskning, udvikling og produktion af medicinalprodukter og andre former for medicinalrelaterede produkter, herunder også medicinal uddannelse, samt al virksomhed, som efter bestyrelsens skøn er beslægtet hermed.
Address
Gammel Kongevej 60
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.330 | 9.035 | 13.859 | 17.002 | 21.049 | 23.241 | 20.758 | 22.615 | 150.732 | 174.845 | 228.372 | 109.907 | 174.279 |
| Staff expenses | -1.918 | -4.028 | -7.576 | -8.929 | -12.907 | -16.517 | -16.206 | -17.946 | -22.456 | -21.800 | -19.972 | -18.784 | -15.857 |
| EBITDA | 6.412 | 5.008 | 6.283 | 8.073 | 8.143 | 6.724 | 4.552 | 4.668 | 5.584 | 6.244 | 7.502 | 3.914 | 5.967 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -75 | -82 | -82 | -21 | -15 | -15 | -1 | -0 |
| EBIT | 6.412 | 5.008 | 6.283 | 8.073 | 8.143 | 6.649 | 4.470 | 4.587 | 5.563 | 6.229 | 7.487 | 3.913 | 5.967 |
| Net financials | -188 | -241 | -279 | -461 | -645 | -555 | -538 | -654 | -603 | -949 | -578 | 245 | 368 |
| Profit before tax | 6.224 | 4.767 | 6.003 | 7.612 | 7.497 | 6.094 | 3.932 | 3.933 | 4.960 | 5.280 | 6.918 | 4.157 | 6.335 |
| Tax | 1.658 | 1.677 | 1.843 | 2.254 | 2.006 | 1.598 | 1.175 | 1.115 | 1.190 | 1.384 | 1.634 | 950 | 475 |
| Net profit | 4.565 | 3.090 | 4.161 | 5.358 | 5.491 | 4.496 | 2.757 | 2.818 | 3.770 | 3.896 | 5.284 | 3.208 | 5.860 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 35.787 | 31.632 | 73.496 | 60.082 | 67.271 | 58.995 | 50.142 | 62.884 | 99.008 | 97.742 | 141.250 | 85.028 | 101.309 |
| Equity | 9.799 | 12.889 | 17.050 | 22.408 | 27.899 | 32.396 | 35.153 | 37.970 | 41.740 | 45.636 | 50.920 | 54.128 | 59.988 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.807 | 0 | 0 | 0 | 0 |
| Short-term debt | 25.988 | 18.744 | 56.446 | 37.674 | 39.372 | 26.600 | 14.989 | 24.914 | 55.460 | 52.106 | 90.330 | 30.900 | 41.321 |
| Total debt | 25.988 | 18.744 | 56.446 | 37.674 | 39.372 | 26.600 | 14.989 | 24.914 | 57.268 | 52.106 | 90.330 | 30.900 | 41.321 |
EBITDA margin
3.4%
This company
15.8%
Market median
-78% vs market
20122024
Equity ratio
59.2%
This company
38.2%
Market median
+55% vs market
20122024
Return on equity
9.8%
This company
18.4%
Market median
-47% vs market
20122024
Net profit margin
3.4%
This company
8.1%
Market median
-58% vs market
20122024
Asset turnover
1.72×
This company
1.12×
Market median
+54% vs market
20122024
Debt / equity
0.69×
This company
0.62×
Market median
+11% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JL Management | Management | 2017 | — | — |
PA Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
DR Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
RC Management | Management | 2010 | — | — |
DW Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
MM Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
HA Management | Management | 2017 | — | — |
GS Founder | Founder | 2007 | — | — |
KF Management | Management | 2016 | — | — |
CS Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
AS Management | Management | 2025 | — | — |
CM Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
KB Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2007 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2011 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2007 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2007 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GILEAD SCIENCES DENMARK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jonas Lars Nicklas Sandgren | Management | 0 companies |
| Pau Arbos Vila | Chief Executive Officer | 0 companies |
| Dick Raymond Sundh | Chief Executive Officer | 0 companies |
| Rolf Carlsson | Management | 0 companies |
| Daniel Woods Kemmler | Chief Executive Officer | 0 companies |
| Muhieddine Makkouk | Chief Executive Officer | 0 companies |
| Helene Annika Oscarsson | Management | 0 companies |
| Gilead Sciences Limited | Founder | 0 companies |
| Karl Frans Anders Morén | Management | 0 companies |
| Clemens Schödl | Chief Executive Officer | 0 companies |
| Anna Sophia Melén | Management | 0 companies |
| Carsten Michael Hans Nowotsch | Chief Executive Officer | 0 companies |
| Kennet Brysting | Chief Executive Officer | 0 companies |
| Paul Rutherford Carter | Chairman | 0 companies |
| Juan Peche Marín-Lázaro | Board of Directors | 0 companies |
| Brett Alan Pletcher | Board of Directors | 0 companies |
| Robin Lynn Washington | Board of Directors | 0 companies |
| Andrew Donald Dickinson | Board of Directors | 0 companies |
| John Fairbanks Milligan | Board of Directors | 0 companies |
| Rudolf Ertl | Chairman | 0 companies |
| Simon David Bedson | Board of Directors | 0 companies |
| Pawel Trawkowski | Board of Directors | 0 companies |
| Hans York-Julian Stücker | Chairman | 0 companies |
| Janet Elizabeth Dorling | Board of Directors | 0 companies |
| John Andrew Jorden | Board of Directors | 0 companies |
| Gregg Huber Alton | Board of Directors | 0 companies |
| Josephine Yang Comiskey | Board of Directors | 0 companies |